Predictors of Ability to Work in Multiple Sclerosis
CPT: Pharmacometrics & Systems Pharmacology · 2025
DOI: 10.1002/psp4.70143 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2025. Verfasst von Gustaf J Wellhagen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Multiple sclerosis (MS) is a chronic disorder that typically shows accumulation of disability, affecting the ability to work. The disease severity is usually graded by physicians with the expanded disability status scale (EDSS) in the clinic, but patient‐reported outcome questionnaires are also available, like the Multiple Sclerosis Impact Scale (MSIS‐29) or Fatigue Scale for Motor and Cognitive Functions (FSMC). The aim of this work was to investigate the quantitative link between disease severity and the number of days with MS‐related sickness benefits from registry data (the Swedish MS registry and the Swedish Social Insurance Agency's Micro Data for Analyzes of Social Insurance registry). An item response theory model for the disability was built, linking the EDSS, MSIS‐29, and FSMC to the same underlying disease construct through five correlated latent variables. A Markov state model for the level of sickness benefits was also developed, in which the disease severities from the disability model were tested as covariates, on top of age. The latent variable for EDSS was the most important predictor of work ability. Patients with low disability (EDSS < 3) hardly had any sickness benefit days, while patients with severe disability (EDSS ≥ 6) were found to spend over 50% of their time with sickness benefits. Physical aspects of the disease were found to be more important than psychological aspects in predicting work ability. This underlines the patient‐specific nature of MS, and the need for predictive models such as these to evaluate treatment effects, make risk assessments, and calculate societal and individual costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Uppsala University, Uppsala, Sweden.
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Gustaf J Wellhagen, Sebastian Ueckert, Elisabet Nielsen, Joachim Burman, Mats O Karlsson
Zitieren
APA
Wellhagen, G. J., Ueckert, S., Nielsen, E., Smith, C., Li, X., Burman, J., & Karlsson, M. O. (2025). Predictors of Ability to Work in Multiple Sclerosis. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.70143
Vancouver
Wellhagen GJ, Ueckert S, Nielsen E, Smith C, Li X, Burman J, et al. Predictors of Ability to Work in Multiple Sclerosis. CPT: Pharmacometrics & Systems Pharmacology. 2025. doi:10.1002/psp4.70143
BibTeX
@article{Wellhagen2025,
author = {Wellhagen, Gustaf J and Ueckert, Sebastian and Nielsen, Elisabet and Smith, Carl and Li, Xinyi and Burman, Joachim and Karlsson, Mats O},
title = {Predictors of Ability to Work in Multiple Sclerosis},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2025},
doi = {10.1002/psp4.70143}
}
EUVIMED